The independent source for health policy research, polling, and news.
14,921 - 14,940 of 112,185 Results
In other pharmaceutical news, Incyte will pay $12.6 million to settle a kickbacks scandal; reports cover new "natural killer" cells cancer treatments; and a $100 million investment will boost efforts using artificial intelligence to develop gene therapies.
According to a new West Health-Gallup survey, 16% of Americans are sticking with current employer out of fear of losing health benefits. That number is even greater for the two poorest-income tiers. In some economic good news, unemployment claims drop to a new pandemic low and hunger rates fall, too.
House Democratic leaders announced a series of bills expected to come up for a vote in May. One is on workplace protections for pregnant employees and another aims to combat increasing hate crimes against Asian Americans. In related news, lawmakers heard testimony Thursday on rising maternal deaths, especially among Black people.
From perks like beer to free public transit, reports talk of efforts to reach more citizens with the covid vaccination program and to combat hesitancy: Half a million Texans apparently haven't come back for their second shot.
The data show that the United States has undercounted by about 300,000 deaths, for a total of approximately 900,000. Meanwhile, health experts warn that variants and the slowing pace of vaccinations could cause another deadly surge this winter.
The strong enrollment numbers could help Democrats make the case that some of their changes to the Affordable Care Act should become permanent, Axios reports.
Moderna said in its financial report that the vaccine was well tolerated by the kids who received it in the phase 2/3 clinical testing. In other development news, a study of health care workers confirms covid shots do reduce covid infections.
FDA authorization of the Pfizer/BioNTech vaccine for children ages 12-15 is expected soon. Other news is on scholarship raffles, mask and vaccine mandates in schools and universities, and more.
And if the World Trade Organization measure is approved, it is unlikely that doses manufactured as a result would get where they are desperately needed for months or longer. But the move may get pharmaceutical companies to the bargaining table.
And rival Moderna said Thursday it plans to initiate a rolling submission to the FDA for its vaccine this month, CNBC reported.
Today's early morning highlights from the major news organizations.
Opinion writers tackle masks, vaccines and variants.
Editorial pages delve into these public health issues.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
Meanwhile, Bloomberg reports on Canadian shortages of AstraZeneca and Moderna shots, and the AP covers Native American efforts to help.
India's ongoing covid crisis continues to break records, as Bloomberg reports on worries about the nation's ability to track covid variants, and CNBC notes the impact it could have on global pandemic efforts.
In other news, six children are hospitalized for E. coli in Washington state; North Carolina saw an HIV surge in 2020; a study identifies higher risk of heart disease in young, Black women; and the opioid trial continues in West Virginia.
And in Florida, the Department of Education tells schools that Gov. Ron DeSantis' orders aimed at rolling back local coronavirus protections don't apply to them.
The San Diego-based provider was hit with a cyberattack May 1, forcing its patient portal offline. Big Tech's role in California's health system, the Theranos trial and a link between hospital doctors and low-value care are also in the news.
At least 68 applications for approval to market new products were affected by inspections being delayed during the pandemic, according to the FDA, including seven that represented a medical advancement.
© 2026 KFF